HealthQuill Articles by: HealthQuill
US regulator, the FDA has approved Gilead Sciences, Inc.'s supplemental new drug application for treating chronic hepatitis B virus in paediatric patients six years of age and older.
Drugs Health Pharma

FDA nod for Gilead to expand hepatitis drug to six years or older patients

HQ Team March 28, 2024: US regulator, the FDA has approved Gilead Sciences, Inc.’s supplemental new drug application for treating chronic hepatitis B

Read More
Australia’s carbon offset scheme, a central feature of climate policy in the country for two decades, to regenerate forests has had negligible impact on woody vegetation cover and carbon sequestration, a study found.
Climate Health Pharma

Australia’s carbon offset scheme has ‘negligible impact,’ a ‘failure’

HQ Team March 28, 2024: Australia’s carbon offset scheme, a central feature of climate policy in the country for two decades, to regenerate

Read More
overuse of cannabis can result in impaired memory
Drugs Health Pharma

FDA clears Akebia’s drug to treat anaemia in acute kidney disease

HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia

Read More
The size of the human brain is getting larger and the bigger size may reduce the potential of overall age-related dementia, according to a study.
Drugs Health Pharma

Human brain size getting larger, has potential to cut dementia risk

HQ Team March 27, 2024: The size of the human brain is getting larger and the bigger size may reduce the potential of

Read More
Humans transmit more viruses in domestic and wild animals than the other way around, scientists found after analyzing 12 million viral genomes from public databases.
Drugs Health Pharma

People spread more virus to animals, not the other way around: Scientists

HQ Team March 27, 2024: Humans transmit more viruses in domestic and wild animals than the other way around, scientists found after analyzing

Read More
US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side effects.
Drugs Health Pharma

Viking Therapeutics’ weight-loss drug shows ‘positive’ results in early trials

US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side

Read More
The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to treat pulmonary arterial hypertension.
Drugs Health Pharma

US regulator clears Merck’s lung therapy after ‘significant’ results

 HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to

Read More
The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to “unreasonable and substantial risk” of illness or injury.
Drugs Medical Pharma

FDA attempts a second time to ban electrical stimulation devices

HQ Team March 26, 2024: The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to “unreasonable and

Read More
A trip through any of the Kerala villages would reveal many palatial mansions, some of them with one or two elderly inhabitants and many locked up forever. 
Drugs Health Opinion Pharma

Opinion: Empty Nest syndrome grips elderly in southern Indian state

By Aparna S March 26, 2024: With a high literacy rate, the migration rates in India’s southern state of Kerala have always been

Read More
Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises in heart diseases, for up to 1.03 billion euros ($1.1 billion).
Drugs Health Pharma

Novo to buy Cardior for $1.1b to expand cardiovascular segment

HQ Team March 25, 2024: Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises

Read More